Medical Health & Life Science Research News

Coronary stents market expected to reach USD 6.4 billion by 2024

Coronary stents market expected to reach USD 6.4 billion by 2024

Research delivers insight by type, material, application, end-user, geography till 2024 . Global Coronary Stents Market, By Type (Dual Therapy Stent, Bioresorbable Vascular Scaffold, Drug Eluting Stent (DES) (Paclitaxel, Limus-Based Drugs), Bio-Engineered Stent, Bare Metal Stent),By Absorption Rate (Slow-Absorption DES, Fast-Absorption (DES)), By Material (Stainless Steel, Cobalt Alloy Metal, Gold, Tantalum, Nitinol, Polymers), Rate (Slow-Absorption Stents, Fast-Absorption Stents), By Application (Coronary Artery Disease, Peripheral Artery Disease), By End-User (Hospitals, Cardiac Centers, Others), By Geography (North America, Europe, Asia-Pacific, Middle East And Africa, South America, Rest Of The World) – Industry Trends And Forecast To 2024

- Advertising -

Global coronary stents market is expected to reach USD 6.4 billion by 2024 from USD 5.3 billion in 2016, at a CAGR of 2.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Request for Sample Report @ databridgemarketresearch.com/req…s-forecast-2024/

The global coronary stents market is segmented on the basis of product type, portability, application, end-user, and geography.

Browse Full Report with Details TOC @ databridgemarketresearch.com/repor…ds-forecast-2024/

On the basis of type, the global coronary stents market is segmented into dual therapy stent, bioresorbable vascular scaffold (BVS), drug eluting stent (DES), bio-engineered stent, bare metal stent.

- Advertising -

On the basis of application, the coronary stents market is segmented into coronary artery disease, and peripheral artery disease.

The market is also segmented on the basis of end-user into hospitals, and cardiac centres.

Based on geography, the market is segmented into five geographical regions:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa  
  • Rest of the World.

The geographical regions are further segmented into major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

The Global Coronary Stent Market Report contains an in-depth profiling of the key market players, along with the recent developments (new product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market.

Some of the major players operating in this market are

  • Abbott Vascular
  • SciTech
  • Boston Scientific Corporation
  • Minvasys
  • Medinol Ltd
  • iVascular SLU
  • Elixir Medical Corporation
  • Inspire MD
  • Stentys SA
  • Hexacath
  • Medtronic
  • Andramed GmbH
  • Cordis Corporation
  • Orbusneich
  • Eurocor GmbH
  • Comed B.V.
  • Endocor GmbH
  • MicroPort Scientific Corporation
  • Amaranth Medical, Inc.
  • Terumo Corporation
  • Degania Silicone Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • InSitu Technologies Inc.
  • Alvimedica
  • Biotronik SE & Co. KG
  • AMG International GmbH
  • Arthesys
  • Lepu Medical
  • Translumina GmbH
  • Accura
  • Svelte Medical
  • B. Braun Melsungen AG  
  • Eucatech AG

Inquiry before Access @ databridgemarketresearch.com/inqui…s-forecast-2024/

Table Of Content:

  1. INTRODUCTION

       1.1. OVERVIEW OF THE GLOBAL CORONARY STENTS MARKET

       1.2. MARKET SEGMENTATION & COVERAGE

                1.2.1. CURRENCY AND PRICING 

                1.2.2. LIMITATION

                1.2.3. STAKEHOLDERS

  1. RESEARCH METHODOLOGY

       2.1. KEY TAKEAWAYS

       2.2. ARRIVING AT THE GLOBAL CORONARY STENTS MARKET SIZE

                2.2.1. MARKET CRACKDOWN APPROACH 

                2.2.2. COMPANY REVENUE AND MARKET SHARE ANALYSIS

                2.2.3. DATA TRIANGULATION

                2.2.4. KEY DATA POINTS FROM PRIMARY SOURCES

                2.2.5. KEY DATA POINTS FROM SECONDARY SOURCES

                2.2.6. PORTER’S FIVE FORCES MATRIX

       2.3. GLOBAL CORONARY STENTS MARKET: RESEARCH SNAPSHOT

       2.4. ASSUMPTIONS

  1. MARKET LANDSCAPE SUMMARY
  2. PREMIUM INSIGHTS

       4.1. OVERVIEW

       4.2. GLOBAL CORONARY STENTS MARKET: KEY PRIMARY INSIGHTS

       4.3. MARKET OVERVIEW

                4.3.1. DRIVERS

                4.3.2. RESTRAINTS

                4.3.3. OPPOTUNITIES

                4.3.4. THREATS

       4.4. KEY MARKET TRENDS AND UPCOMING TECHNOLOGIES

  1. GLOBAL CORONARY STENTS MARKET, BY TYPE

       5.1. OVERVIEW

       5.2. DUAL THERAPY STENT

       5.3. BIORESORBABLE VASCULAR SCAFFOLD

       5.4. DRUG ELUTING STENT (DES)

                5.4.1. PACLITAXEL

                5.4.2. IMUS-BASED DRUGS

       5.5. BIO-ENGINEERED STENT

       5.6. BARE METAL STENT

  1. GLOBAL CORONARY STENTS MARKET, BY ABSORPTION RATE

       6.1. SLOW-ABSORPTION DES

       6.2. FAST-ABSORPTION (DES)

  1. GLOBAL CORONARY STENTS MARKET, BY MATERIAL

       7.1. OVERVIEW

       7.2. STAINLESS STEEL

       7.3. COBALT ALLOY METAL

       7.4. GOLD

       7.5. TANTALUM

       7.6. NITINOL

        7.7. POLYMERS

  1. GLOBAL CORONARY STENTS MARKET, BY RATE

       8.1. OVERVIEW

       8.2. SLOW-ABSORPTION STENTS

       8.3. FAST-ABSORPTION STENTS

  1. GLOBAL CORONARY STENTS MARKET, BY APPLICATION

       9.1. CORONARY ARTERY DISEASE

       9.2. PERIPHERAL ARTERY DISEASE

  1. GLOBAL CORONARY STENTS MARKET, BY END USER

       10.1. HOSPITALS

       10.2. CARDIAC CENTERS

       10.3. OTHERS

  1. GLOBAL CORONARY STENTS MARKET, BY GEOGRAPHY

       11.1. COUNTRYWISE CORONARY STENTS MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)

                11.1.1. NORTH AMERICA

                            11.1.1.1. U.S.

                            11.1.1.2. CANADA

                            11.1.1.3. MEXICO

                11.1.2. EUROPE

                            11.1.2.1. GERMANY

                            11.1.2.2. FRANCE

                            11.1.2.3. U.K.

                            11.1.2.4. ITALY

                            11.1.2.5. SPAIN

                            11.1.2.6. RUSSIA

                            11.1.2.7. TURKEY

                            11.1.2.8. BELGIUM

                            11.1.2.9. NETHERLANDS

                            11.1.2.10. SWITZERLAND

                            11.1.2.11. REST OF EUROPE

                11.1.3. ASIA-PACIFIC (APAC)

                            11.1.3.1. JAPAN

                            11.1.3.2. CHINA

                            11.1.3.3. SOUTH KOREA

                            11.1.3.4. INDIA

                            11.1.3.5. AUSTRALIA

                            11.1.3.6. SINGAPORE

                            11.1.3.7. THAILAND

                            11.1.3.8. MALAYSIA

                            11.1.3.9. INDONESIA

                            11.1.3.10. PHILIPPINES

                            11.1.3.11. REST OF APAC

                11.1.4. SOUTH AMERICA

                            11.1.4.1. BRAZIL

                            11.1.4.2. REST OF SOUTH AMERICA

                11.1.5. MIDDLE EAST AND AFRICA

                            11.1.5.1. SOUTH AFRICA

                            11.1.5.2. REST OF MIDDLE EAST AND AFRICA

       11.2. KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES

  1. GLOBAL CORONARY STENTS MARKET: COMPETITIVE LANDSCAPE

       12.1. GLOBAL CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

       12.2. U.S. CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

       12.3. EUROPE CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

       12.4. APAC CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

       12.5. SOUTH AMERICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

       12.6. MIDDLE EAST AND AFRICA CORONARY STENTS MARKET: COMPANY SHARE ANALYSIS

       12.7. MERGERS & ACQUISITIONS

       12.8. NEW PRODUCT DEVELOPMENT & APPROVALS

       12.9. EXPANSIONS

       12.10. REGULATORY CHANGES

       12.11. PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS            

  1. GLOBAL CORONARY STENTS MARKET, COMPANY PROFILES

       13.1. ABBOTT VASCULAR

                13.1.1. OVERVIEW

                13.1.2. SWOT ANALYSIS

                13.1.3. PRODUCT PORTFOLIO

                13.1.4. REVENUE ANALYSIS

                13.1.5. ANALYSTS VIEW

       13.2. SCITECH

                13.2.1. OVERVIEW

                13.2.2. SWOT ANALYSIS

                13.2.3. PRODUCT PORTFOLIO

                13.2.4. REVENUE ANALYSIS

                13.2.5. ANALYSTS VIEW

       13.3. BOSTON SCIENTIFIC CORPORATION

                13.3.1. OVERVIEW

                13.3.2. SWOT ANALYSIS

                13.3.3. PRODUCT PORTFOLIO

                13.3.4. REVENUE ANALYSIS

                13.3.5. ANALYST VIEW

       13.4. MEDINOL LTD

                13.4.1. OVERVIEW

                13.4.2. SWOT ANALYSIS

                13.4.3. PRODUCT PORTFOLIO

                13.4.4. REVENUE ANALYSIS

                13.4.5. ANALYSTS VIEW

       13.5. IVASCULAR SLU

                13.5.1. OVERVIEW

                13.5.2. SWOT ANALYSIS

                13.5.3. PRODUCT PORTFOLIO

                13.5.4. REVENUE ANALYSIS

               13.5.5. ANALYSTS VIEW

       13.6. STENTYS SA

                13.6.1. OVERVIEW

                13.6.2. SWOT ANALYSIS

                13.6.3. PRODUCT PORTFOLIO

                13.6.4. REVENUE ANALYSIS

                13.6.5. ANALYSTS VIEW

       13.7. ELIXIR MEDICAL CORPORATION

                13.7.1. OVERVIEW

                13.7.2. SWOT ANALYSIS

                13.7.3. PRODUCT PORTFOLIO

                13.7.4. REVENUE ANALYSIS

                13.7.5. ANALYSTS VIEW

       13.8. INSPIRE MD

                13.8.1. OVERVIEW

                13.8.2. SWOT ANALYSIS

                13.8.3. PRODUCT PORTFOLIO

                13.8.4. REVENUE ANALYSIS

                13.8.5. ANALYSTS VIEW

       13.9. HEXACATH

                13.9.1. OVERVIEW

                13.9.2. SWOT ANALYSIS

                13.9.3. PRODUCT PORTFOLIO

                13.9.4. REVENUE ANALYSIS

                13.9.5. ANALYSTS VIEW

       13.10. MEDTRONIC

                13.10.1. OVERVIEW

                13.10.2. SWOT ANALYSIS

                13.10.3. PRODUCT PORTFOLIO

                13.10.4. REVENUE ANALYSIS

                13.10.5. ANALYSTS VIEW

       13.11. ORBUSNEICH

                13.11.1. OVERVIEW

                13.11.2. SWOT ANALYSIS

                13.11.3   PRODUCT PORTFOLIO

                13.11.4   REVENUE ANALYSIS

                13.11.5   ANALYSTS VIEW

       13.12. ANDRAMED GMBH

                13.12.1. OVERVIEW

                13.12.2. SWOT ANALYSIS

                13.12.3. PRODUCT PORTFOLIO

                13.12.4. REVENUE ANALYSIS

                13.12.5. ANALYSTS VIEW

       13.13. CORDIS CORPORATION

                13.13.1. OVERVIEW

                13.13.2. SWOT ANALYSIS

                13.13.3. PRODUCT PORTFOLIO

                13.13.4. REVENUE ANALYSIS

                13.13.5. ANALYSTS VIEW

       13.14. ENDOCOR GMBH

                13.14.1. OVERVIEW

                13.14.2. SWOT ANALYSIS

                13.14.3. PRODUCT PORTFOLIO

                13.14.4. REVENUE ANALYSIS

                13.14.5. ANALYSTS VIEW

       13.15. EUROCOR GMBH

                13.15.1. OVERVIEW

                13.15.2. SWOT ANALYSIS

                13.15.3. PRODUCT PORTFOLIO

                13.15.4. REVENUE ANALYSIS

                13.15.5. ANALYSTS VIEW

       13.16. COOK MEDICAL.

                13.16.1. OVERVIEW

                13.16.2. SWOT ANALYSIS

                13.16.3. PRODUCT PORTFOLIO

                13.16.4. REVENUE ANALYSIS

                13.16.5. ANALYSTS VIEW

       13.17. MICROPORT SCIENTIFIC CORPORATION

                13.17.1. OVERVIEW

                13.17.2. SWOT ANALYSIS

                13.17.3. PRODUCT PORTFOLIO

                13.17.4. REVENUE ANALYSIS

                13.17.5. ANALYSTS VIEW

       13.18. DEGANIA SILICONE LTD.

                13.18.1. OVERVIEW

                13.18.2. SWOT ANALYSIS

                13.18.3. PRODUCT PORTFOLIO

                13.18.4. REVENUE ANALYSIS

                13.18.5. ANALYSTS VIEW

       13.19. TERUMO CORPORATION

                13.19.1. OVERVIEW

                13.19.2. SWOT ANALYSIS

                13.19.3. PRODUCT PORTFOLIO

                13.19.4. REVENUE ANALYSIS

                13.19.5. ANALYSTS VIEW

       13.20. MERIL LIFE SCIENCES PVT. LTD.

                13.20.1. OVERVIEW

                13.20.2. SWOT ANALYSIS

                13.20.3. PRODUCT PORTFOLIO

                13.20.4. REVENUE ANALYSIS

                13.20.5. ANALYSTS VIEW

       13.21. ALVIMEDICA

                13.21.1. OVERVIEW

                13.21.2. SWOT ANALYSIS

                13.21.3. PRODUCT PORTFOLIO

                13.21.4. REVENUE ANALYSIS

                13.21.5. ANALYSTS VIEW

       13.22. ELIXIR MEDICAL CORPORATION

                13.22.1. OVERVIEW

                13.22.2. SWOT ANALYSIS

                13.22.3. PRODUCT PORTFOLIO

                13.22.4. REVENUE ANALYSIS

                13.22.5. ANALYSTS VIEW

       13.23. INSITU TECHNOLOGIES INC.

                13.23.1. OVERVIEW

                13.23.2. SWOT ANALYSIS

                13.23.3. PRODUCT PORTFOLIO

                13.23.4. REVENUE ANALYSIS

                13.23.5. ANALYSTS VIEW

       13.24. BIOTRONIK SE & CO. KG

                13.24.1. OVERVIEW

                13.24.2. SWOT ANALYSIS

                13.24.3. PRODUCT PORTFOLIO

                13.24.4. REVENUE ANALYSIS

                13.24.5. ANALYSTS VIEW

       13.25. AMG INTERNATIONAL GMBH

                13.25.1. OVERVIEW

                13.25.2. SWOT ANALYSIS

                13.25.3. PRODUCT PORTFOLIO

                13.25.4. REVENUE ANALYSIS

                13.25.5. ANALYSTS VIEW

       13.26. ARTHESYS

                13.26.1. OVERVIEW

                13.26.2. SWOT ANALYSIS

                13.26.3. PRODUCT PORTFOLIO

                13.26.4. REVENUE ANALYSIS

                13.26.5. ANALYSTS VIEW

       13.27. TRANSLUMINA GMBH

                13.27.1. OVERVIEW

                13.27.2. SWOT ANALYSIS

                13.27.3. PRODUCT PORTFOLIO

                13.27.4. REVENUE ANALYSIS

                13.27.5. ANALYSTS VIEW

       13.28. LEPU MEDICAL

                13.28.1. OVERVIEW

                13.28.2. SWOT ANALYSIS

                13.28.3. PRODUCT PORTFOLIO

                13.28.4. REVENUE ANALYSIS

                13.28.5. ANALYSTS VIEW

       13.29. ACCURA

                13.29.1. OVERVIEW

                13.29.2. SWOT ANALYSIS

                13.29.3. PRODUCT PORTFOLIO

                13.29.4. REVENUE ANALYSIS

                13.29.5. ANALYSTS VIEW

       13.30. CELONOVA BIOSCIENCES, INC.

                13.30.1. OVERVIEW

                13.30.2. SWOT ANALYSIS

                13.30.3. PRODUCT PORTFOLIO

                13.30.4. REVENUE ANALYSIS

                13.30.5. ANALYSTS VIEW

       13.31. MINVASYS

                13.31.1. OVERVIEW

                13.31.2. SWOT ANALYSIS

                13.31.3. PRODUCT PORTFOLIO

                13.31.4. REVENUE ANALYSIS

                13.31.5. ANALYSTS VIEW

       13.32. SVELTE MEDICAL

                13.32.1. OVERVIEW

                13.32.2. SWOT ANALYSIS

                13.32.3. PRODUCT PORTFOLIO

                13.32.4. REVENUE ANALYSIS

                13.32.5. ANALYSTS VIEW

       13.33. B. BRAUN MELSUNGEN AG

                13.33.1. OVERVIEW

                13.33.2. SWOT ANALYSIS

                13.33.3. PRODUCT PORTFOLIO

                13.33.4. REVENUE ANALYSIS

                13.33.5. ANALYSTS VIEW

       13.34. EUCATECH AG

                13.34.1. OVERVIEW

                13.34.2. SWOT ANALYSIS

                13.34.3. PRODUCT PORTFOLIO

                13.34.4. REVENUE ANALYSIS

                13.34.5. ANALYSTS VIEW

  1. APPENDIX
  2. ABOUT DATA BRIDGE MARKET RESEARCH

 

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany profile: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...